JP2022540668A5 - - Google Patents

Info

Publication number
JP2022540668A5
JP2022540668A5 JP2022502215A JP2022502215A JP2022540668A5 JP 2022540668 A5 JP2022540668 A5 JP 2022540668A5 JP 2022502215 A JP2022502215 A JP 2022502215A JP 2022502215 A JP2022502215 A JP 2022502215A JP 2022540668 A5 JP2022540668 A5 JP 2022540668A5
Authority
JP
Japan
Prior art keywords
polymorph
degrees
mixture
xrpd patterns
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022502215A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022540668A (ja
JP7624431B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/042387 external-priority patent/WO2021011807A1/en
Publication of JP2022540668A publication Critical patent/JP2022540668A/ja
Publication of JP2022540668A5 publication Critical patent/JP2022540668A5/ja
Priority to JP2025007662A priority Critical patent/JP7755090B2/ja
Application granted granted Critical
Publication of JP7624431B2 publication Critical patent/JP7624431B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022502215A 2019-07-17 2020-07-16 (r)-n-(5-(5-エチル-1,2,4-オキサジアゾール-3-イル)-2,3-ジヒドロ-1h-インデン-1-イル)-1-メチル-1h-ピラゾール-4-カルボキサミドの多形 Active JP7624431B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025007662A JP7755090B2 (ja) 2019-07-17 2025-01-20 (r)-n-(5-(5-エチル-1,2,4-オキサジアゾール-3-イル)-2,3-ジヒドロ-1h-インデン-1-イル)-1-メチル-1h-ピラゾール-4-カルボキサミドの多形

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962875350P 2019-07-17 2019-07-17
US62/875,350 2019-07-17
PCT/US2020/042387 WO2021011807A1 (en) 2019-07-17 2020-07-16 Polymorphs of (r)-n-(5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1h-inden-1-yl)-1-methyl-1h-pyrazole-4-carboxamide

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025007662A Division JP7755090B2 (ja) 2019-07-17 2025-01-20 (r)-n-(5-(5-エチル-1,2,4-オキサジアゾール-3-イル)-2,3-ジヒドロ-1h-インデン-1-イル)-1-メチル-1h-ピラゾール-4-カルボキサミドの多形

Publications (3)

Publication Number Publication Date
JP2022540668A JP2022540668A (ja) 2022-09-16
JP2022540668A5 true JP2022540668A5 (cg-RX-API-DMAC10.html) 2023-07-25
JP7624431B2 JP7624431B2 (ja) 2025-01-30

Family

ID=71995103

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022502215A Active JP7624431B2 (ja) 2019-07-17 2020-07-16 (r)-n-(5-(5-エチル-1,2,4-オキサジアゾール-3-イル)-2,3-ジヒドロ-1h-インデン-1-イル)-1-メチル-1h-ピラゾール-4-カルボキサミドの多形
JP2025007662A Active JP7755090B2 (ja) 2019-07-17 2025-01-20 (r)-n-(5-(5-エチル-1,2,4-オキサジアゾール-3-イル)-2,3-ジヒドロ-1h-インデン-1-イル)-1-メチル-1h-ピラゾール-4-カルボキサミドの多形

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025007662A Active JP7755090B2 (ja) 2019-07-17 2025-01-20 (r)-n-(5-(5-エチル-1,2,4-オキサジアゾール-3-イル)-2,3-ジヒドロ-1h-インデン-1-イル)-1-メチル-1h-ピラゾール-4-カルボキサミドの多形

Country Status (25)

Country Link
US (1) US20220315571A1 (cg-RX-API-DMAC10.html)
EP (2) EP4487911A1 (cg-RX-API-DMAC10.html)
JP (2) JP7624431B2 (cg-RX-API-DMAC10.html)
KR (1) KR20220084008A (cg-RX-API-DMAC10.html)
CN (3) CN118908951A (cg-RX-API-DMAC10.html)
AU (1) AU2020313965B2 (cg-RX-API-DMAC10.html)
BR (1) BR112022000494A2 (cg-RX-API-DMAC10.html)
CA (1) CA3144975A1 (cg-RX-API-DMAC10.html)
CL (1) CL2022000054A1 (cg-RX-API-DMAC10.html)
DK (1) DK3999180T3 (cg-RX-API-DMAC10.html)
ES (1) ES2980885T3 (cg-RX-API-DMAC10.html)
FI (1) FI3999180T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20240713T1 (cg-RX-API-DMAC10.html)
HU (1) HUE066891T2 (cg-RX-API-DMAC10.html)
IL (1) IL289875B1 (cg-RX-API-DMAC10.html)
LT (1) LT3999180T (cg-RX-API-DMAC10.html)
MX (1) MX2022000504A (cg-RX-API-DMAC10.html)
PH (1) PH12022550123A1 (cg-RX-API-DMAC10.html)
PL (1) PL3999180T3 (cg-RX-API-DMAC10.html)
PT (1) PT3999180T (cg-RX-API-DMAC10.html)
RS (1) RS65611B1 (cg-RX-API-DMAC10.html)
SI (1) SI3999180T1 (cg-RX-API-DMAC10.html)
SM (1) SMT202400224T1 (cg-RX-API-DMAC10.html)
TW (1) TWI865562B (cg-RX-API-DMAC10.html)
WO (1) WO2021011807A1 (cg-RX-API-DMAC10.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202006296YA (en) 2018-01-19 2020-08-28 Cytokinetics Inc Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors
JP7438148B2 (ja) 2018-06-26 2024-02-26 サイトキネティックス, インコーポレイテッド 心臓サルコメア阻害剤
EP3814343B1 (en) 2018-06-26 2023-01-11 Cytokinetics, Inc. Cardiac sarcomere inhibitors
MA53491A (fr) 2018-08-31 2021-09-15 Cytokinetics Inc Inhibiteurs de sarcomes cardiaques
MX2022000498A (es) 2019-07-17 2022-02-03 Cytokinetics Inc Polimorfos de (r)-n-(5-(5-isopropil-1,2,4-oxadiazol-3-il)-2,3-dihi dro-1h-inden-1-il) -2-metil-2h- tetrazol-5-carboxamida.
KR20240015622A (ko) 2021-03-04 2024-02-05 싸이토키네틱스, 인코포레이티드 심장 근절 억제제
EP4370116B1 (en) 2021-07-16 2025-01-15 Cytokinetics, Inc. Aficamten dosage regimens for treating obstructive hypertrophic cardiomyopathy
JP2024530111A (ja) 2021-08-03 2024-08-16 サイトキネティックス, インコーポレイテッド アフィカムテンを調製するための工程
US20240091203A1 (en) 2022-07-20 2024-03-21 Cytokinetics, Incorporated Methods for treating non-obstructive hypertrophic cardiomyopathy
JP2025525913A (ja) 2022-08-04 2025-08-07 サイトキネティックス, インコーポレイテッド 閉塞性肥大型心筋症を治療するための方法
WO2024134498A1 (en) 2022-12-22 2024-06-27 Assia Chemical Industries Ltd. Solid state forms of aficamten and process for preparation thereof
CN120712262A (zh) * 2023-03-02 2025-09-26 苏州科睿思制药有限公司 Aficamten的共晶及其制备方法和用途
WO2025198687A1 (en) 2024-03-20 2025-09-25 Cytokinetics, Incorporated Methods for treating heart diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202006296YA (en) * 2018-01-19 2020-08-28 Cytokinetics Inc Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors
JP2024530111A (ja) * 2021-08-03 2024-08-16 サイトキネティックス, インコーポレイテッド アフィカムテンを調製するための工程

Similar Documents

Publication Publication Date Title
JP2022542803A5 (cg-RX-API-DMAC10.html)
FI3999180T3 (fi) (r)-n-(5-(5-etyyli-1,2,4-oksadiatsol-3-yyli)-2,3-dihydro-1h-inden-1–yyli)-1–metyyli-1h-pyratsoli-4-karboksamidin polymorfeja
JP5498786B2 (ja) 新規なマロン酸スルホンアミド誘導体およびその医薬用途
JP4422477B2 (ja) ヘテロアリールスルホニル側鎖を有するアントラニル酸アミド、その製造方法、その医薬または診断助剤としての使用、およびこの化合物を含有する医薬製剤
AU2014239995B2 (en) Salt of omecamtiv mecarbil and process for preparing salt
CN110357789B (zh) 作为dhodh抑制剂的n-取代丙烯酰胺衍生物及其制备和用途
CA2897273A1 (en) Benzylamine derivatives
CN102766139B (zh) 阿齐沙坦的多晶型物及其制备方法
JP2023535447A (ja) ベルモスジル及びベルモスジル塩の固体形態
JP2024508526A5 (cg-RX-API-DMAC10.html)
CN105218448A (zh) 一种1-甲基-3-二氟甲基-4-吡唑甲酸的合成方法
AU779931B2 (en) Novel processes for making- and a new crystalline form of- leflunomide
HUP0203444A2 (hu) (S)-2-Etoxi-3-[4-{2-[4-(metánszulfonil-oxi)-fenil]-etoxi}-fenil]-propionsav kristályos formája, eljárás az előállítására, ezt tartalmazó gyógyszerkészítmény és alkalmazása
WO2012153158A1 (en) Process for the manufacture of dabigatran etexilate and intermediates thereof
JP2000063363A (ja) 新規なトリアゾール誘導体
JP2022540678A5 (cg-RX-API-DMAC10.html)
CN105523999B (zh) 一种达比加群酯中间体的合成方法
JP2024546844A5 (cg-RX-API-DMAC10.html)
WO2004000813A1 (ja) フェノキシピリジン誘導体又はその塩
JP2007535512A (ja) 新規なβ−アゴニスト、その製造方法及びその薬物としての使用
JP2009040702A (ja) 新規アミドプロピオン酸誘導体を含有する医薬組成物
RU2018135072A (ru) Кристаллическая (2s,4r)-5-(5'-хлор-2'-фтор-[1,1'-бифенил]-4-ил)-2-(этоксиметил)-4-(3-гидроксиизоксазол-5-карбоксамидо)-2-метилпентановая кислота и ее применения
WO2012090221A1 (en) Novel salts of imatinib
RU2022103861A (ru) Полиморфы (r)-n-(5-(5-этил-1,2,4,-оксадиазол-3-ил)-2,3-дигидро-1н-инден-1-ил)-1-метил-1н-пиразол-4-карбоксамида
RU2022103863A (ru) Полиморфы (r)-n-(5-(5-изопропил-1,2,4-оксадиазол-3-ил)-2,3-дигидро-1h-инден-1-ил)-2-метил-2h-тетразол-5-карбоксамида